Sincerity-oriented, integrity-based, service as the top priority.
Established
Total Site Area
Jilin Seven Dimensions Biotechnology Co., Ltd. (here in after referred to as "the Company"), established in 2016, is a wholly-owned subsidiary of Beijing Seven Dimensions Health Technology Co., Ltd. With years of dedication to biotechnology, medical devices, and healthcare equipment sectors, the Company has evolved into an integrated modern high-tech enterprise encompassing scientific R&D, manufacturing, sales, and service systems.
Headquartered at No. 666 Fuxing Road, Jiutai Economic Development Zone, Changchun ,Jilin Province, the Company occupies a total area of 30,150 square meters, including a factory building area of 10,000 square meters. It currently employs over 120d staff members, 56 of whom hold professional technical and managerial positions. The Company has been recognized with prestigious honors including National High-Tech Enterprise, Jilin Provincial "Little Giant" Enterprise, Jilin Provincial & Changchun Municipal "Specialized, Sophisticated, and Innovative" Enterprise, Model Enterprise for Integrity Culture Construction, Advanced Collective for Pharmaceutical Scientific Regulation and High-Quality Development of Medical Industry in Jilin Province, and Changchun Municipal Enterprise Technology Center. Additionally, it has obtained certifications for ISO 9001 & ISO 13485 Quality Management Systems, Occupational Health and Safety Management System, and Environmental Management System, underscoring its commitment to operational excellence.
Technology as the Foundation, Innovation as the Source
Guided by a philosophy of relentless excellence in product development, we continuously innovate technologies and offerings. Rooted in the medical device and healthcare industries, our current product portfolio focuses on medical dressing devices and disinfection products, while actively expanding R&D into healthcare products, cosmetics, functional foods, and dietary supplements. We have established 15 proprietary brands, including Leihao, Qingxi, and Haibike, earning strong market recognition through high-quality products and services.
Technology as the Foundation, Innovation as the Source.We maintain robust R&D investments and collaborate closely with leading research institutions and specialized academies to pioneer cutting-edge technologies. Since initiating dedicated research efforts in 2017, we have achieved significant breakthroughs, accumulating 44 proprietary intellectual property rights and successfully commercializing 39 technological innovations.
Our facilities include a 4,000+ sqm 100,000-class purification production workshop, equipped with modern intelligent production lines, automated manufacturing systems, and precision testing instruments. Leveraging core R&D and industrial capabilities, we currently achieve an annual output value exceeding RMB 50 million. The company has forged long-term strategic partnerships with industry leaders such as Winner , Mayinglong, Baiyunshan, Xiuzheng, and Hynaut. Through visionary market strategies and a nationwide sales and service network, we deliver timely, efficient, and diversified solutions to meet evolving domestic demands.Our leapfrog growth trajectory exemplifies Seven Dimensions Bio’s thriving journey of innovation and expansion.
Corporate Innovation & Core Technologies
Guided by the principle of “Quality as the foundation, innovation as the driving force, and integrity as the cornerstone of collaboration,” we maintain long-term partnerships with prestigious research institutions and academic bodies, including Changchun University of Chinese Medicine, College of Life Sciences at Jilin University, First Clinical Hospital of Jilin Provincial Academy of Chinese Medicine Sciences, and Siping Central People’s Hospital. Since commencing operations in 2017, we have filed and secured over 40 product patents. Moving forward, we will deepen expertise in existing technologies while accelerating breakthroughs in high-end innovations.Our commercialized products currently focus on gynecological, proctological, and ENT (Ear, Nose, Throat) medical dressings, as well as irrigation and lavage solutions. Prominent R&D pipelines include recombinant humanized collagen and studies on the bioactivity and biocompatibility of biological protein products, now advancing toward technology transfer. To bolster innovation, we operate an 800-square-meter proprietary R&D laboratory staffed by a 40+ member technical team, equipped with state-of-the-art infrastructure. Our vision is to evolve into a technology-driven enterprise where innovations drive market success, and market growth fuels further R&D advancements.
Product
All currently approved products are Class II medical devices, primarily medical dressings in gel, liquid, and adhesive formats. Our portfolio includes owned brands such as Qingxi, Shunqing, Haibike, Alimei, Leihao, Bangfuqing, Wanmin, Bangbeiqing, Xinyan, and Youxiang, distributed to hospitals and pharmacies with strong market reception.
2 Class III medical device candidates have completed R&D and preclinical preparations, now entering clinical trials.
10 Class II medical devices under development: 4 proprietary projects and 6 collaborative initiatives with Jilin University, Tianjin University, and specialized research teams. These span biotechnology, chemistry, molecular diagnostics, and optoelectronics, targeting applications in wound care, in vitro diagnostics, rehabilitation, and patient monitoring
Development Goals & Vision
With a 30,000-square-meter eco-friendly garden-style campus, 4,000-square-meter 100,000-class cleanroom production facilities, mature manufacturing systems, and a professional management team, we have laid the foundation for comprehensive production capacity modernization. As we scale operations, our output is poised for sustained growth, driving a dual leap in production capacity and market reputation.
Guided by our mission to “safeguard human well-being,” we advance with unrelenting dedication, striving to achieve strategic goals in innovative R&D, technological advancement, and production capacity expansion.
Powering a Healthier China
Enabling a Brighter Future
National Advisory Hotline
86 18500770088 (WeChat Synchronization)
Contact Address
No. 666 Fuxing Road,Changchun Jiutai Economic Development Zone, Jilin Province
Little Red Book
WeChat Public Number